Rapid effects of extrafine beclomethasone dipropionate/formoterol fixed combination inhaler on airway inflammation and bronchoconstriction in asthma: a randomised controlled trial
<p>Abstract</p> <p>Background</p> <p>The dose-dependent anti-inflammatory effects of a recent fixed combination of extrafine beclomethasone dipropionate/formoterol (BDP/F) were investigated using non-invasive markers of inflammation, exhaled nitric oxide (NO) and adenos...
Main Authors: | O'Connor Brian J, Collarini Sara, Poli Gianluigi, Brindicci Caterina, Spinola Monica, Acerbi Daniela, Barnes Peter J, Leaker Brian |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-12-01
|
Series: | BMC Pulmonary Medicine |
Online Access: | http://www.biomedcentral.com/1471-2466/11/60 |
Similar Items
-
Extrafine combination beclomethasone dipropionate/ formoterol therapy in obstructive lung diseases
by: I. N. Trofimenko, et al.
Published: (2020-08-01) -
Safety of hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol.
by: Thompson, P, et al.
Published: (1998) -
Comparison of Dry-Powder Inhaler and Pressurized Metered-Dose Inhaler Formulations of Extrafine Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrronium in Patients with COPD: The TRI-D Randomized Controlled Trial
by: Beeh KM, et al.
Published: (2021-01-01) -
Small Airways, Big Problem: Extrafine beclomethasone/formoterol in asthma and chronic obstructive pulmonary disease
by: Ashfaq Hasan, et al.
Published: (2021-01-01) -
Penggunaan Extrafine Beclometason Diproprionat/Formoterol Fumarat pada PPOK [Combined Extrafine Beclomethason Diproprionat/Formoteral Fumarat in COPD]
by: Sakinatus Syarifah, et al.
Published: (2019-05-01)